Table 2.
TNM stage | n | 3-year DFS (%) | X 2 | P value | 3-year OS (%) | X 2 | P value |
---|---|---|---|---|---|---|---|
I | 10 | 100 | 14.16 | 0.0008 | 100 | 8.23 | 0.0164 |
II | 57 | 94.6 | 100 | ||||
III | 105 | 71.8 | 80.8 |
DFS disease-free survival, OS overall survival, TNM tumor–node–metastasis
TNM stage | n | 3-year DFS (%) | X 2 | P value | 3-year OS (%) | X 2 | P value |
---|---|---|---|---|---|---|---|
I | 10 | 100 | 14.16 | 0.0008 | 100 | 8.23 | 0.0164 |
II | 57 | 94.6 | 100 | ||||
III | 105 | 71.8 | 80.8 |
DFS disease-free survival, OS overall survival, TNM tumor–node–metastasis